Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

What To Expect From Tenet Healthcare's (THC) Q3 Earnings

Published 10/31/2019, 12:03 AM
Updated 07/09/2023, 06:31 AM

Tenet Healthcare Corporation (NYSE:THC) will report third-quarter 2019 results on Nov 4, after market close.

The Zacks Consensus Estimate for earnings is pegged at 28 cents, indicating a 3.4% decline from the year-ago reported figure.

In the last reported quarter, the company’s earnings of 56 cents per share, beat the Zacks Consensus Estimate by 27.3% and grew 14.3% year over year. This upside is primarily driven by the Hospital & Other segment, volume growth in hospital portfolio and earnings growth at United Surgical Partners International (USPI).

Let’s see how things are shaping up prior to this announcement:

The company’s to-be-reported quarter is likely to have suffered softer revenues, affected by lower admissions. Number of licensed beds might have decreased due to the company’s divestitures.

The consensus mark for adjusted patient admissions and licensed beds implies a decrease of 3.7% and 4%, respectively, from the prior-year reported numbers.

Nevertheless, adjusted patient days are expected to have improved marginally in the third quarter. The consensus mark for the same indicates an uptick of 3.8% from the year-ago reported figure.

The company’s USPI segment is likely to have witnessed better surgical and non-surgical volumes, retaining its second-quarter momentum. Moreover, Tenet Healthcare’s Conifer segment is expected to have seen growth on the back of its initiative to boost cost and service structure.

What the Quantitative Model Predicts

Our proven model does not conclusively predict an earnings beat for Tenet Healthcare this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Earnings ESP: Tenet Healthcare has an Earnings ESP of 0.00%. This is because both the Most Accurate Estimate and the Zacks Consensus Estimate are pegged at 28 cents. You can see the complete list of today’s Zacks #1 Rank stocks here.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Rank: Tenet Healthcare sports a Zacks Rank #1, which increases the predictive power of ESP. However, the company’s 0.00% ESP makes surprise prediction difficult for the stock this time around.

Stocks to Consider

Some stocks worth considering from the medical sector with the perfect mix of elements to surpass estimates in the next releases are as follows:

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) is set to report third-quarter earnings on Nov 5. The stock has a Zacks Rank #3 and an Earnings ESP of +1.34%.

AmerisourceBergen Corporation (NYSE:ABC) is slated to announce third-quarter earnings on Nov 7. The stock has an Earnings ESP of +0.55% and is Zacks #3 Ranked.

Aurora Cannabis Inc. (TSX:ACB) is set to report third-quarter earnings on Nov 11. It has a Zacks Rank of 3 and an Earnings ESP of +25.76%.

Free: Zacks’ Single Best Stock Set to Double

Today you are invited to download our just-released Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.

This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.

Download Free Report Now >>


3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Acadia Healthcare Company, Inc. (ACHC): Free Stock Analysis Report

Tenet Healthcare Corporation (THC): Free Stock Analysis Report

AmerisourceBergen Corporation (ABC): Free Stock Analysis Report

Aurora Cannabis Inc. (ACB): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.